In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir

INTRODUCTION: Daclatasvir is a non-structural protein 5A (NS5A) inhibitor with activity against hepatitis C virus (HCV) genotypes 1–6 in vitro, and asunaprevir is a non-structural protein 3 (NS3) protease inhibitor with activity against genotypes 1, 4, 5, and 6. This study evaluates potential option...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Infect Dis Ther
Auteurs principaux: Friborg, Jacques, Zhou, Nannan, Han, Zhou, Yang, Xiaoyan, Falk, Paul, Mendez, Patricia, McPhee, Fiona
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2014
Sujets:
Brief Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363215/
https://ncbi.nlm.nih.gov/pubmed/25516102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-014-0052-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires